제 제넨바이오: directors' dealings · South Korea · DART (FSS) Explore the full management transaction log of 제넨바이오, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 제넨바이오 has logged 38 public disclosures. The latest transaction was disclosed on 14 March 2024 (Other). Among the most active insiders: 메리츠증권. The full history is openly available.
Last declaration on 14 March 2024
All Executives38 Thresholds0 Prospectus0 Other0
Declarations 38 total
● Executives
Executives · 14 Mar 2024 (filed)
● Executives
Executives · 13 Feb 2024 (filed)
● Executives
Executives · 9 Jan 2024 (filed)
● Executives
Executives · 9 Jan 2024 (filed)
● Executives
Executives · 30 Nov 2023 (filed)
● Executives
Executives · 12 Apr 2023 (filed)
● Executives
Executives · 12 Apr 2023 (filed)
● Executives
Executives · 31 Mar 2023 (filed)
● Executives
Executives · 16 Mar 2023 (filed)
● Executives
Executives · 10 Mar 2023 (filed)
● Executives
Executives · 9 Mar 2023 (filed)
● Executives
Executives · 10 Jan 2023 (filed)
● Executives
Executives · 9 Dec 2022 (filed)
● Executives
Executives · 30 Sept 2022 (filed)
● Executives
Executives · 23 Sept 2022 (filed)
● Executives
Executives · 10 Aug 2022 (filed)
● Executives
Executives · 8 Aug 2022 (filed)
● Executives
Executives · 5 Apr 2022 (filed)
● Executives
Executives · 21 Mar 2022 (filed)
● Executives
Executives · 14 Mar 2022 (filed)
● Executives
Executives · 6 Dec 2021 (filed)
● Executives
Executives · 6 Dec 2021 (filed)
● Executives
Executives · 5 Nov 2021 (filed)
● Executives
Executives · 3 Nov 2021 (filed)
● Executives
Executives · 23 Jul 2021 (filed)
25 of 38 declarations
Load more (13 remaining)